Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma

Por Fathi, Amir T., Nahed, Brian V., Wander, Seth A., Iafrate, A. John, Borger, Darrell R., Hu, Ranliang, Thabet, Ashraf, Cahill, Daniel P., Perry, Ashley M., Joseph, Christelle P., Muzikansky, Alona, Chi, Andrew S.
Publicado no Oncologist (2016)

Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer

Por Russo, Mariangela, Siravegna, Giulia, Blaszkowsky, Lawrence S., Corti, Giorgio, Crisafulli, Giovanni, Ahronian, Leanne G., Mussolin, Benedetta, Kwak, Eunice L., Buscarino, Michela, Lazzari, Luca, Valtorta, Emanuele, Truini, Mauro, Jessop, Nicholas A., Robinson, Hayley E., Hong, Theodore S., Mino-Kenudson, Mari, Di Nicolantonio, Federica, Thabet, Ashraf, Sartore-Bianchi, Andrea, Siena, Salvatore, Iafrate, A. John, Bardelli, Alberto, Corcoran, Ryan B.
Publicado no Cancer Discov (2015)

Convergent loss of PTEN leads to clinical resistance to a PI3Kα inhibitor

Por Juric, Dejan, Castel, Pau, Griffith, Malachi, Griffith, Obi L., Won, Helen H., Ellis, Haley, Ebbesen, Saya H., Ainscough, Benjamin J., Ramu, Avinash, Iyer, Gopa, Shah, Ronak H., Huynh, Tiffany, Mino-Kenudson, Mari, Sgroi, Dennis, Isakoff, Steven, Thabet, Ashraf, Elamine, Leila, Solit, David B., Lowe, Scott W., Quadt, Cornelia, Peters, Malte, Derti, Adnan, Schegel, Robert, Huang, Alan, Mardis, Elaine R., Berger, Michael F., Baselga, José, Scaltriti., Maurizio
Publicado no Nature (2014)